MHRA Board Meeting – 15 November 2022 MHRA (Medicines and Healthcare products Regulatory Agency) Board Meeting – 15 November 2022 The MHRA Board will meet in public... MHRA Board Meeting – 15 November 2022
Water Framework Directive Proposal Published Water Framework Directive Proposal Published The European Commission (EC) is proposing stronger rules on ambient air, surface and groundwater pollutants,... Water Framework Directive Proposal Published
MHRA Delivery Plan 2021-2023 – Updates for Year Two MHRA Delivery Plan 2021-2023 – Updates for Year Two The Delivery Plan 2021-2023 ‘Putting patients first; A... MHRA Delivery Plan 2021-2023 – Updates for Year Two
MHRA September Board Meeting Documents MHRA September Board Meeting Documents The agenda and board papers from the MHRA board meeting on 20... MHRA September Board Meeting Documents
MHRA Publishes Marketing Authorisations Granted between 1-14 October 2022 MHRA’s list of marketing authorisations granted between 1-14 October 2022 MHRA granted five OTC licences between 1-14 October 2022. Details... MHRA Publishes Marketing Authorisations Granted between 1-14 October 2022
MHRA Public Assessment Report – Reclassification of Neutrogena T/Gel Therapeutic Shampoo MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA has published the Public... MHRA Public Assessment Report – Reclassification of Neutrogena T/Gel Therapeutic Shampoo
CMDh October 2022 Meeting – Report CMDh October 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh October 2022 Meeting – Report
European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published The European Commission has published the Staff... European Commission – Structured Dialogue Security of Medicines Supply Staff Working Document Published
EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making The European Medicines Agency (EMA) has... EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making
AESGP Hearing at HMPC Meeting Report – May 2022 AESGP Hearing at HMPC Meeting Report – May 2022 EMA has published the report of the AESGP hearing at the... AESGP Hearing at HMPC Meeting Report – May 2022
HMA 109th Meeting Highlights – September 2022 HMA 109th Meeting Highlights – September 2022 The Heads of Medicines Agencies (HMA) have published the highlights... HMA 109th Meeting Highlights – September 2022
Titanium Dioxide – Global Safety Review Updates Titanium Dioxide – Global Safety Review Updates AESGP has provided a summary of new developments related to titanium dioxide globablly,... Titanium Dioxide – Global Safety Review Updates
